{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 acts as a deubiquitinating enzyme for EIF5A2, removing ubiquitin chains and thereby preventing its proteasomal degradation. This stabilization of EIF5A2 promotes the progression of anaplastic thyroid carcinoma.",
  "functions": [
    {
      "function": "EIF5A2 Stability",
      "arrow": "activates",
      "cellular_process": "ATXN3 functions as a deubiquitinating enzyme for the eukaryotic translation initiation factor 5A2 (EIF5A2).",
      "effect_description": "By removing ubiquitin chains from EIF5A2, ATXN3 prevents its proteasomal degradation, thereby increasing its stability and protein levels.",
      "biological_consequence": [
        "ATXN3 deubiquitinates EIF5A2 → EIF5A2 is stabilized against proteasomal degradation → EIF5A2 protein levels increase → Elevated EIF5A2 promotes anaplastic thyroid carcinoma progression."
      ],
      "specific_effects": [
        "ATXN3-mediated stabilization of EIF5A2 promotes the progression of anaplastic thyroid carcinoma.",
        "ATXN3 and EIF5A2 protein levels are positively correlated in anaplastic thyroid carcinoma tissues."
      ],
      "evidence": [
        {
          "paper_title": "The deubiquitinating enzyme ATXN3 promotes the progression of anaplastic thyroid carcinoma by stabilizing EIF5A2",
          "doi": "10.1016/j.mce.2021.111440",
          "authors": "Shimin Zhuang, Jing Xie, Jing Zhen, Liangyun Guo, Zhengdong Hong, Feihong Li, Debin Xu",
          "journal": "Molecular and Cellular Endocrinology",
          "year": 2021,
          "assay": "Co-Immunoprecipitation, Ubiquitination assay",
          "species": "human",
          "relevant_quote": "Mechanistically, ATXN3 promotes EIF5A2 expression by directly binding to EIF5A2 to reduce its ubiquitination and degradation.",
          "pmid": "34428509"
        }
      ],
      "_context": {
        "type": "direct",
        "query_protein": null,
        "chain": null
      },
      "interaction_effect": "activates",
      "direction": "main_to_primary",
      "interaction_direction": "main_to_primary",
      "pmids": [
        "34428509"
      ]
    }
  ],
  "arrow": "activates",
  "direction": "primary_to_main",
  "intent": "deubiquitination",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "mechanism": "ATXN3 functions as a deubiquitinating enzyme for the eukaryotic translation initiation factor 5A2 (EIF5A2).",
  "effect": "By removing ubiquitin chains from EIF5A2, ATXN3 prevents its proteasomal degradation, thereby increasing its stability and protein levels.",
  "summary": "ATXN3 activates EIF5A2 to modulate eif5a2 stability, ultimately affecting elevated eif5a2 promotes anaplastic thyroid carcinoma progression.",
  "evidence": [
    {
      "paper_title": "The deubiquitinating enzyme ATXN3 promotes the progression of anaplastic thyroid carcinoma by stabilizing EIF5A2",
      "doi": "10.1016/j.mce.2021.111440",
      "authors": "Shimin Zhuang, Jing Xie, Jing Zhen, Liangyun Guo, Zhengdong Hong, Feihong Li, Debin Xu",
      "journal": "Molecular and Cellular Endocrinology",
      "year": 2021,
      "assay": "Co-Immunoprecipitation, Ubiquitination assay",
      "species": "human",
      "relevant_quote": "Mechanistically, ATXN3 promotes EIF5A2 expression by directly binding to EIF5A2 to reduce its ubiquitination and degradation."
    }
  ],
  "arrow_notation": "ATXN3 --activates--> EIF5A2:",
  "protein_a": "EIF5A2",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-18T20:57:38.939269Z",
  "last_updated": "2025-11-18T20:57:38.939269Z"
}